BACKGROUND: Transgender inclusive and gender affirmative healthcare includes asking patients about gender identity and sex assigned at birth through what is known as the "2-step" methodology. In May 2016, the sexually transmitted disease (STD) clinic in Seattle, WA switched from using a 1-step to a 2-step gender identity question. We aimed to determine if the updated questions increased ascertainment of transgender and gender nonconforming (TGNC) patients and used the improved gender identity data to describe the human immunodeficiency virus/STD risk profile of TGNC patients. METHODS: We conducted a pre-post analysis comparing the proportion of patients that identified as TGNC during the year before and after implementation of the 2-step questions. Gender identity and medical history questions were ascertained using a computer-assisted self-interview. The 2-step question included 2 new gender response options: non-binary/genderqueer and write-in. RESULTS: Institution of the 2-step question resulted in a 4.8-fold increase in patients who were identified as TGNC: 36 (0.5%) of 6635 to 172 (2.4%) of 7025 patients (P < 0.001). After implementation, 89 patients identified as non-binary/genderqueer (51.7% of TGNC patients). The proportion of patients identified as transgender men and women increased from 0.2% to 0.5% (P = 0.002) and 0.4% to 0.6% (P = 0.096), respectively. Non-binary patients' human immunodeficiency virus/sexually transmitted infection risk profile was distinct from that of transgender and cisgender men who have sex with men, suggesting that distinguishing subpopulations within the TGNC population is important for risk stratification. CONCLUSIONS: Using a 2-step gender identity question and including non-binary/genderqueer options increased our clinic's ascertainment of TGNC patients and more accurately captured gender identity among STD clinic patients.
BACKGROUND: Transgender inclusive and gender affirmative healthcare includes asking patients about gender identity and sex assigned at birth through what is known as the "2-step" methodology. In May 2016, the sexually transmitted disease (STD) clinic in Seattle, WA switched from using a 1-step to a 2-step gender identity question. We aimed to determine if the updated questions increased ascertainment of transgender and gender nonconforming (TGNC) patients and used the improved gender identity data to describe the human immunodeficiency virus/STD risk profile of TGNC patients. METHODS: We conducted a pre-post analysis comparing the proportion of patients that identified as TGNC during the year before and after implementation of the 2-step questions. Gender identity and medical history questions were ascertained using a computer-assisted self-interview. The 2-step question included 2 new gender response options: non-binary/genderqueer and write-in. RESULTS: Institution of the 2-step question resulted in a 4.8-fold increase in patients who were identified as TGNC: 36 (0.5%) of 6635 to 172 (2.4%) of 7025 patients (P < 0.001). After implementation, 89 patients identified as non-binary/genderqueer (51.7% of TGNC patients). The proportion of patients identified as transgender men and women increased from 0.2% to 0.5% (P = 0.002) and 0.4% to 0.6% (P = 0.096), respectively. Non-binary patients' human immunodeficiency virus/sexually transmitted infection risk profile was distinct from that of transgender and cisgender men who have sex with men, suggesting that distinguishing subpopulations within the TGNC population is important for risk stratification. CONCLUSIONS: Using a 2-step gender identity question and including non-binary/genderqueer options increased our clinic's ascertainment of TGNC patients and more accurately captured gender identity among STD clinic patients.
Authors: Clair A Kronk; Avery R Everhart; Florence Ashley; Hale M Thompson; Theodore E Schall; Teddy G Goetz; Laurel Hiatt; Zackary Derrick; Roz Queen; A Ram; E Mae Guthman; Olivia M Danforth; Elle Lett; Emery Potter; Simón E D Sun; Zack Marshall; Ryan Karnoski Journal: J Am Med Inform Assoc Date: 2022-01-12 Impact factor: 7.942
Authors: Kacie M Kidd; Gina M Sequeira; Claudia Douglas; Taylor Paglisotti; David J Inwards-Breland; Elizabeth Miller; Robert W S Coulter Journal: Pediatrics Date: 2021-05-18 Impact factor: 9.703
Authors: Joanne D Stekler; Lauren R Violette; Hollie A Clark; Sarah J McDougal; Lisa A Niemann; David A Katz; Pollyanna R Chavez; Laura G Wesolowski; Steven F Ethridge; Vanessa M McMahan; Andy Cornelius-Hudson; Kevin P Delaney Journal: JMIR Res Protoc Date: 2020-01-27
Authors: Susanne Drückler; Ceranza Daans; Elske Hoornenborg; Henry De Vries; Martin den Heijer; Maria Prins; Sophie Kuizenga Wessel; Martijn van Rooijen Journal: Sex Transm Infect Date: 2021-04-19 Impact factor: 4.199
Authors: Medhavi Bole; Christine M Khosropour; Sara N Glick; Lindley A Barbee; Matthew R Golden; Shireesha Dhanireddy; Julia C Dombrowski Journal: Sex Transm Dis Date: 2022-07-04 Impact factor: 3.868
Authors: Jean Olivier Twahirwa Rwema; Carrie E Lyons; Sara Herbst; Benjamin Liestman; Julien Nyombayire; Sosthenes Ketende; Amelia Mazzei; Oluwasolape Olawore; Sabin Nsanzimana; Placidie Mugwaneza; Aflodis Kagaba; Patrick S Sullivan; Susan Allen; Etienne Karita; Stefan D Baral Journal: J Int AIDS Soc Date: 2020-10 Impact factor: 5.396